Abdelmawla, N, Mitchell, A (2006) Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms. Advances in Psychiatric Treatment
Aleman, A, Kahn, RS (2001) Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European Neuropsychopharmacology
Allen, MH (2000) Managing the agitated psychotic patient: a reappraisal of the evidence. Journal of Psychiatry
61 (suppl 14): 11–20.
Altamura, AC, Sassella, F, Santini, A et al (2003) Intramuscular preparations of antipsychotics: uses of relevance in clinical practice. Drugs
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA.
Andrezina, R, Josiassen, RC, Marcus, RN et al (2006) Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology (Berlin)
Battaglia, J, Lindborg, SR, Alaka, K et al (2003) Calming versus sedative effects of intramuscular olanzapine in agitated patients. American Journal of Emergency Medicine
Battaglia, J (2004) Intramuscular olanzapine: treating acute agitation in psychosis and bipolar mania. Current Psychiatry
Battaglia, J (2005) Pharmacologic management of acute agitation. Drugs
Bellnier, TJ (2002) Continuum of care: stabilizing the acutely agitated patient. American Journal of Health-system Pharmacy
59 (suppl 5): s12–8.
Bristol-Myers Squibb (2003) Aripiprazole (Abilify) Package Insert. Bristol-Myers Squibb.
Buckley, PF, Noffsinger, SG, Smith, DA et al (2003) Treatment of the psychotic patient who is violent. Psychiatric Clinics of North America
Burris, KD, Molski, TF, Xu, C et al (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. Journal of Pharmacology and Experimental Therapeutics
Canas, F (2007) Management of agitation in the acute psychotic patient: efficacy without excessive sedation. European Neuropsychopharmacology
17 (suppl 2): s108–14.
Chengappa, KNR, Goldstein, JM, Greenwood, M et al (2003) A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clinical Therapeutics
Citrome, L (2004a) New treatments for agitation. Psychiatric Quarterly
Citrome, L, Brook, S, Warrington, L et al (2004b) Ziprasidone versus haloperidol for the treatment of agitation. Annals of Emergency Medicine
44 (suppl): S22.
Citrome, L (2007) Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. Journal of Clinical Psychiatry
Cohen-Mansfield, J (1986) Agitated behavior in the elderly: a conceptual review. Journal of the American Geriatrics Society
Corrigan, JD (1989) Development of a scale for assessment of agitation following traumatic brain injury. Journal of Clinical and Experimental Neuropsychology
Currier, GW, Allen, MH (2000) Physical and chemical restraint in the psychiatric emergency service. Psychiatric Services
Currier, GW, Simpson, GM (2001) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. Journal of Clinical Psychiatry
Currier, G, Allen, MH, Bunney, EB et al (2004a) Novel therapies for treating acute agitation. Journal of Emergency Medicine
27 (suppl 1): S13–8.
Currier, GW, Chou, JCY, Feifel, D et al (2004b) Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam. Journal of Clinical Psychiatry
Currier, G, Trenton, AJ, Walsh, PG et al (2006a) A pilot, open-label safety study of quetiapine for treatment of moderate psychotic agitation in the emergency setting. Journal of Psychiatric Practice
Currier, GW, Medori, (2006b) Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergencies. Journal of Psychiatric Practice
Currier, GW, Citrome, LL, Zimbroff, DL et al (2007) Intramuscular aripiprazole in the control of agitation. Journal of Psychiatric Practice
Daniel, DG, Potkin, SG, Reeves, KR et al (2001) Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology (Berlin)
Daniel, DG, Zimbroff, DL, Swift, RH et al (2004) The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy. International Clinical Psychopharmacology
De Fruyt, Demyttenaere K (2004) Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances. European Psychiatry
Downey, LV, Zun, LS, Gonzales, SJ (2007) Frequency of alternative to restraints and seclusion and uses of agitation reduction techniques in the emergency department. General Hospital Psychiatry
DuBuske, LM (1999) Second-generation antihistamines: the risk of ventricular arrhythmias. Clinical Therapeutics
Eli Lilly (2006) Olanzapine (Zyprexa) US Prescribing Information. Eli Lilly.
Eli Lilly (2008) Highlights of Prescribing Information: Zyprexa (Olanzapine) Tablets, Zyprexa Zydis (Olanzapine) Orally Disintegrating Tablets, Zyprexa Intramuscular (Olanzapine) for Injection. Product Information, Revised March 10, 2008. Eli Lilly (http://pi.lilly.com/us/zyprexa-pi.pdf).
Escobar, R, San, L, Perez, V et al (2008) Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: results form NATURA study [in Spanish]. Actas Españolas de Psiquiatría
Expert Consensus Panel for Behavioral Emergencies (2005) The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice
11 (suppl 1): 5–108.
Fisher, WA (1994) Restraint and seclusion: a review of the literature. American Journal of Psychiatry
Foster, S, Kessel, J, Berman, ME et al (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. International Clinical Psychopharmacology
Ganesan, ML, Bilsker, D, Khanbhai, I (2005) Effectiveness of quetiapine for the management of aggressive psychosis in the emergency psychiatric setting: a naturalistic uncontrolled trial. International Journal of Psychiatry in Clinical Practice
Glassman, AH (2001) Antipsychotic drugs: prolonged QTc interval, Torsades de pointes, and sudden death. American Journal of Psychiatry
Greenblatt, DJ, Blaskovich, PD, Nuwayser, ES et al (2005) Clonazepam pharmacokinetics: comparison of subcutaneous microsphere injection with multiple-dose oral administration. Journal of Pharmacology
Hatta, K, Kawabata, T, Yoshida, K et al (2008) Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. General Hospital Psychiatry
Karagianis, JL, Dawe, IC, Thakur, A et al (2001) Rapid tranquilization with olanzapine in acute psychosis: a case series. Journal of Clinical Psychiatry
62 (suppl 2): 12–6.
Kay, SR, Fiszbein, A, Opler, LA (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin
Kinon, BJ, Stauffer, VL, Kollack-Walker, S et al (2008) Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia. Journal of Psychopharmacology
Kopecky, HJ, Kopecky, CR, Yudofsky, SC (1998) Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients. Psychiatric Quarterly
Lejeune, J, Larmo, I, Chrzanowski, W et al (2004) Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis. International Clinical Psychopharmacology
Leonard, BE (1992) Fundamentals of Psychopharmacology. John Wiley & Sons.
Lesem, MD, Zajecka, JM, Swift, RH et al (2001) Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. Journal of Clinical Psychiatry
Lindenmayer, J (2000) The pathophysiology of agitation. Journal of Clinical Psychiatry
61 (suppl 14): 5–10.
Marder, SR (2006) A review of agitation in mental illness: treatment guidelines and current therapies. Journal of Clinical Psychiatry
67 (suppl 10): 13–21.
McAllister-Williams, RH, Ferrier, IN (2002) Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. British Journal of Psychiatry
McCue, RE, Waheed, R, Urcuyo, L et al (2006) Comparative effectiveness of second-generation antipsychotics and haloperidol in acute schizophrenia. British Journal of Psychiatry
Meehan, K, Zhang, F, David, S et al (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Journal of Clinical Psychopharmacology
Mendelowitz, A (2004) The utility of intramuscular ziprasidone in the management of acute psychotic agitation. Annals of Clinical Psychiatry
Mendoza, R, Djenderedjian, AH, Adams, J et al (1987) Midazolam in acute psychotic patients with hyperarousal. Journal of Clinical Psychiatry
Miller, DD (2004) Atypical antipsychotics: sleep, sedation, and efficacy. Primary Care Companion to the Journal of Clinical Psychiatry
6 (suppl 2): 3–7.
Mohr, P, Pecenák, J, Svestka, J et al (2005) Treatment of acute agitation in psychotic disorders. Neuroendocrinology Letters
Montout, C, Casadebaig, F, Lagnaoui, R et al (2002) Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophrenia Research
National Collaborating Centre for Nursing and Supportive Care (2005) Violence: The Short-term Management of Disturbed/Violent Behaviour in In-Patient Psychiatric Settings and Emergency Departments (Clinical Practice Guideline 25). National Institute for Health and Clinical Excellence (http://www.nice.org.uk/nicemedia/live/10964/29719/29719.pdf).
Ness, G, House, A, Ness, AR (2000) Aggression and violent behaviour in general practice: population based survey in the north of England. BMJ
Pereira, S, Paton, C, Walkert, LM et al (2005) Treatment of acute behavioural disturbance: a UK national survey of rapid tranquillisation. Journal of Psychiatric Intensive Care
Petit, J (2005) Management of the acutely violent patient. Psychiatric Clinics of North America
Preval, H, Klotz, SG, Southard, R et al (2005) Rapid-acting intramuscular ziprasidone in the psychiatric emergency service: a naturalistic violence. General Hospital Psychiatry
Raja, M, Azzoni, A (2001) Novel antipsychotics and acute dystonic reactions. International Journal of Neuropsychopharmacology
Raja, M, Azzoni, A (2003) Comparison of three antipsychotics in the emergency room setting. Human Psychopharmacology
Ray, WA, Meredith, S, Thapa, PB et al (2001) Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry
Tran-Johnson, TK, Sack, DA, Marcus, RN et al (2007) Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind placebo controlled trial. Journal of Clinical Psychiatry
TREC Collaborative Group (2003) Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ
Tulloch, KJ, Zed, PJ (2004) Intramuscular olanzapine in the management of acute agitation. Annals of Pharmacotherapy
Van Schaick, EA, Lechat, P, Remmerie, BM et al (2003) Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers. Clinical Therapeutics
Villari, V, Rocca, P (2008) Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Progress in Neuro-Psychopharmacology and Biological Psychiatry
Wise, R (2000) New restraint standards will change your practice. ED Management
Wright, P, Birkett, M, David, SR et al (2001) Double-blind, placebo controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. American Journal of Psychiatry
Wright, P, Meehan, K, Birkett, M et al (2003) A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clinical Therapeutics
Yudofsky, SC, Kopecky, HJ, Kunik, M et al (1997) The Overt Agitation Severity Scale for the objective rating of agitation. Journal of Neuropsychiatry and Clinical Neurosciences
Zimbroff, DL, Marcus, RN, Manos, G et al (2007) Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. Journal of Psychopharmacology